| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | -0.07 | 0.1 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.1 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.1 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.1 |